-- Israel Stocks: RadVision, Allot, Medical Compression, Teva
-- B y   S h o s h a n n a   S o l o m o n
-- 2011-12-15T15:37:52Z
-- http://www.bloomberg.com/news/2011-12-15/israel-stocks-radvision-allot-medical-compressions-teva.html
Israel’s  TA-25 Index (TA-25)  gained for a
third time this week, climbing 1.7 percent to 1,093.37 at 4:30
p.m. close in  Tel Aviv . The measure has increased 2.1 percent
this week, paring the drop for the year to 18 percent. Investors
traded about 1.1 billion shekels ($290 million) of shares and
convertible securities, according to bourse data.  The following stocks rose or fell today. Symbols are in
parenthesis.  Allot Communications Ltd.  (ALLT IT) fell the most since
Oct. 2, tumbling 7.7 percent to 64.40 shekels, or the equivalent
of $16.97. The U.S.-traded shares of the Israeli maker of high-
speed networking equipment whose biggest market is Europe
slumped 7.3 percent to $16.77 yesterday on concern European
policy makers will fail to contain the debt crisis.  Israel Chemicals Ltd. (ICL)  , which extracts minerals
from the Dead Sea to make fertilizer and potash, rose for a
second day, advancing 4 percent to 37.02 shekels. The finance
ministry yesterday said talks with the company on royalties and
salt harvesting will conclude soon.  Israel Corp. (ILCO)  ,
which has a 52.32 percent stake in Israel Chemicals according to
Bloomberg data, rose 4.3 percent.  Medical Compression Systems (DBN) Ltd. (MDCL)   surged the
most since Nov. 28, advancing 10 percent to 2.628 shekels. The
maker of non-invasive blood circulation solutions said it was
adding a safety mechanism to its product following U.S. Food and
Drug Administration criticism.  RadVision Ltd. (RVSN)   tumbled the most since October
2009, retreating 14 percent to 31.94 shekels, or the equivalent
of $8.42. The U.S.-traded shares of the maker of video-
conferencing systems slid 12 percent to $8.51 in  New York 
yesterday. RadVision gained 19 percent this week in Tel Aviv on
newspaper reports that Avaya Inc. is in talks to buy the company
for a premium.  Teva Pharmaceutical Industries Ltd. (TEVA)   rose to its
highest level since July 31, gaining 2.7 percent to 158.40
shekels or the equivalent of $41.74. The U.S.-traded shares of
the world’s largest generic drug maker gained 1.3 percent to
$41.24 yesterday.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  